Ridgewood Investments LLC Has $303,000 Position in Smith & Nephew SNATS, Inc. $SNN

Key Points

• Ridgewood Investments LLC reduced its stake in Smith & Nephew SNATS by 86.8% during the second quarter, now holding 9,887 shares valued at $303,000.
• Several institutional investors, including Bessemer Group Inc. and Richards Merrill & Peterson Inc., have significantly increased their stakes, demonstrating heightened interest in the company.
• Smith & Nephew SNATS recently announced a semi-annual dividend of $0.285, with a payout ratio of 26.39% and a yield of 210.0%.

Ridgewood Investments LLC lowered its holdings in shares of Smith & Nephew SNATS, Inc. (NYSE:SNN - Free Report) by 86.8% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,887 shares of the medical equipment provider's stock after selling 65,052 shares during the period. Ridgewood Investments LLC's holdings in Smith & Nephew SNATS were worth $303,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Hexagon Capital Partners LLC boosted its stake in Smith & Nephew SNATS by 63.3% during the first quarter. Hexagon Capital Partners LLC now owns 1,047 shares of the medical equipment provider's stock worth $30,000 after buying an additional 406 shares in the last quarter. Richards Merrill & Peterson Inc. boosted its stake in Smith & Nephew SNATS by 500.0% during the first quarter. Richards Merrill & Peterson Inc. now owns 1,200 shares of the medical equipment provider's stock worth $34,000 after buying an additional 1,000 shares in the last quarter. Bessemer Group Inc. boosted its stake in Smith & Nephew SNATS by 3,471.4% during the first quarter. Bessemer Group Inc. now owns 1,750 shares of the medical equipment provider's stock worth $49,000 after buying an additional 1,701 shares in the last quarter. Banque Transatlantique SA acquired a new stake in Smith & Nephew SNATS during the first quarter worth $52,000. Finally, Hara Capital LLC boosted its stake in Smith & Nephew SNATS by 391.4% during the fourth quarter. Hara Capital LLC now owns 2,457 shares of the medical equipment provider's stock worth $60,000 after buying an additional 1,957 shares in the last quarter. Institutional investors and hedge funds own 25.64% of the company's stock.

Smith & Nephew SNATS Stock Performance

Shares of SNN stock opened at $36.85 on Monday. The company has a debt-to-equity ratio of 0.60, a current ratio of 3.00 and a quick ratio of 1.40. The stock has a 50-day moving average of $35.05 and a 200-day moving average of $30.74. Smith & Nephew SNATS, Inc. has a one year low of $23.69 and a one year high of $38.79. The stock has a market cap of $16.05 billion, a PE ratio of 17.06, a price-to-earnings-growth ratio of 1.02 and a beta of 0.71.

Smith & Nephew SNATS Cuts Dividend

The firm also recently disclosed a semi-annual dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 3rd will be given a $0.285 dividend. The ex-dividend date is Friday, October 3rd. This represents a dividend yield of 210.0%. Smith & Nephew SNATS's payout ratio is currently 26.39%.

Analyst Ratings Changes

Several equities research analysts have recently commented on the stock. Canaccord Genuity Group boosted their target price on shares of Smith & Nephew SNATS from $28.00 to $36.00 and gave the company a "hold" rating in a research note on Monday, August 18th. Wall Street Zen upgraded shares of Smith & Nephew SNATS from a "buy" rating to a "strong-buy" rating in a research note on Saturday, August 30th. Six equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $36.00.

Smith & Nephew SNATS Profile

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.